Staphylococcus aureus (S. aureus) represents one of the most frequent worldwide causes of morbidity and mortality due to an infectious agent. It is a part of the infamous ESKAPE group, which is highly connected with increased rates of healthcare-associated infections and antimicrobial resistance. S. aureus can cause a large variety of diseases. Protein A (PrA) is a cell-wall-anchored protein of S. aureus with multiple key roles in colonization and pathogenesis and can be considered as a marker of S. aureus. The development of aptasensors, having an aptamer as a specific biorecognition element, increases selectivity, especially when working with complex matrices. The association with state-of-the-art materials, such as MXenes, can further improve the analytical performance. A competitive aptasensor configuration based on a ferrocene (Fc)-labeled cDNA hybridized (cDNA-Fc S13) on a specific aptamer (APT) for PrA in the presence of MXene nanosheets was designed for the indirect detection of S. aureus. The aptasensor displayed a linear range of 10-125 nM, an LOD of 3.33 nM, and a response time under 40 min. This configuration has been tested in real samples from volunteers diagnosed with S. aureus infections with satisfactory results, enabling the perspective to develop decentralized devices for the rapid detection of bacterial strains.
Keywords: Staphylococcus aureus; aptasensor; clinical samples; competitive assay; electrochemical detection; protein A.